Published in Cancer Weekly, April 26th, 1999
L. Lee and colleagues from the U.S. National Cancer Institute, Bethesda, Maryland, evaluated the frequency of NY-ESO-1 expression in cultured lung cancer cells to determine if this cancer-testis antigen could be presented for recognition by an HLA-restricted cytolytic T-cell clone specific for NY-ESO-1 ("NY-ESO-1 May Be a Potential Target for Lung Cancer Immunotherapy," Cancer Journal from Scientific American, January-February 1999;5(1):20-25).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.